Detalles de la búsqueda
1.
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.
Rheumatology (Oxford)
; 63(2): 525-533, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208196
2.
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
J Rheumatol
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490668
3.
Does hydroxychloroquine improve patient reported outcomes in patients with lupus?
Lupus
; 30(11): 1790-1798, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304629
4.
Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.
Rheumatology (Oxford)
; 59(2): 281-291, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31302695
5.
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Kidney Int
; 95(1): 219-231, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420324
6.
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
Ann Rheum Dis
; 75(9): 1615-21, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26458737
7.
Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Arthritis Rheum
; 65(8): 2143-53, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23754628
8.
Overview of lupus nephritis management guidelines and perspective from Asia.
Nephrology (Carlton)
; 19(1): 11-20, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23876069
9.
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
Adv Rheumatol
; 64(1): 38, 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38720354
10.
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
Lancet Rheumatol
; 5(10): e584-e593, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251484
11.
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 377(9767): 721-31, 2011 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21296403
12.
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.
Ann Rheum Dis
; 71(11): 1833-8, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22550315
13.
Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G.
Ann Rheum Dis
; 71(5): 777-84, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22233601
14.
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study.
Arthritis Res Ther
; 24(1): 70, 2022 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35287720
15.
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study.
Arthritis Care Res (Hoboken)
; 74(12): 2033-2041, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34197023
16.
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study.
Lancet Rheumatol
; 4(12): e822-e830, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261390
17.
Rheumatoid arthritis management in the APLAR region: Perspectives from an expert panel of rheumatologists, patients and community oriented program for control of rheumatic diseases.
Int J Rheum Dis
; 24(9): 1106-1111, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34375036
18.
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
Int J Rheum Dis
; 23(2): 197-202, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31692250
19.
Lupus education for physicians and patients in a resource-limited setting.
Clin Rheumatol
; 39(3): 697-702, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31691040
20.
Practice Advisory on the Appropriate Use of NSAIDs in Primary Care.
J Pain Res
; 13: 1925-1939, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32821151